TheraRadar

Pharma Intelligence, Simplified

← Back
Data updated: Mar 10, 2026

OTSUKA ICU MEDCL

MetabolicOphthalmology
Specialty

OTSUKA ICU MEDCL is a specialty pharmaceutical company focused on Metabolic, Ophthalmology.

1971
Since
68
Drugs
-
Trials
15
Approved (2yr)